
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Acetaminophen Related Compound A (4-(acetylamino)phenyl acetate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H11NO3Color and Shape:White PowderMolecular weight:193.2Chloroquine Related Compound A (4,7-dichloroquinoline)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormula:C9H5Cl2NColor and Shape:Off-White Brownish Yellow CrystalsMolecular weight:196.9799Temozolomide Related Compound B (3-methyl-1,1-diphenylurea)
CAS:Ureines and their derivatives; salts thereofFormula:C14H14N2OColor and Shape:PowderMolecular weight:226.11061Depramine (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride)
Anti-infective agents, nesoiFormula:C19H22N2Color and Shape:Yellow PowderMolecular weight:278.1783Doxepin Related Compound A (dibenzo[b,e]oxepin-11(6H)-one)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C14H10O2Color and Shape:Beige PowderMolecular weight:210.06808Ticagrelor R,S-Cyclopropyl Isomer
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C23H28F2N6O4SColor and Shape:White Off-White SolidMolecular weight:522.18608Paroxetine Related Compound D ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White Off-White Crystalline PowderMolecular weight:365.83 g/molDoxepin Related Compound C ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C18H19NO·HClColor and Shape:Cream PowderMolecular weight:265.14666Fluoxetine Related Compound B (N-Methyl-3-phenylpropan-1-amine)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C10H15NColor and Shape:Clear Colorless LiquidMolecular weight:149.12045Bisoprolol Related Compound D (1-(4-{[(2-Isopropoxyethoxy)methoxy]methyl}phenoxy)-3-(isopropylamino)propan-2-ol fumarate (2:1) salt)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C19H33NO5)2·C4H4O4Color and Shape:White SolidMolecular weight:827.02Isoflurane Related Compound B (2,2,2-Trifluoroethyl difluoromethyl ether)
CAS:Ethers of monohydric alcohols, nesoiFormula:C3H3F5OColor and Shape:Colorless Clear LiquidMolecular weight:150.05 g/molGlimepiride Related Compound D (Glimepiride 3-isomer, or 1-[[m-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea)
CAS:Sulfonamides, nesoiFormula:C24H34N4O5SColor and Shape:White PowderMolecular weight:490.62Lamotrigine Related Compound B (2,3-dichlorobenzoic acid)
CAS:Aromatic monocarboxylic acids, their anhydrides, halideFormula:C7H4Cl2O2Color and Shape:Beige PowderMolecular weight:191.01Betamethasone Dipropionate Related Compound F (9,11β-Epoxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C28H36O7Color and Shape:White Off-White PowderMolecular weight:484.2461Adapalene Related Compound E (2,2'-Binaphthyl-6,6'-dicarboxylic acid)
CAS:Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormula:C22H14O4Color and Shape:PowderMolecular weight:342.08921Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide)
CAS:Antidepressants, tranquilizers and other psychotherapeutic agents, nesoiFormula:C15H11ClN2O2Color and Shape:White PowderMolecular weight:286.05091Azithromycin Related Compound H (3'-N-{[4-(Acetylamino)phenyl]sulfonyl}-3'-N-demethylazithromycin)
CAS:Sulfonamides, nesoiFormula:C45H77N3O15SColor and Shape:White PowderMolecular weight:931.50754Memantine Related Compound B (3,5-Dimethyladamantane-1-ol)
CAS:Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C12H20OColor and Shape:Off-White Crystalline PowderMolecular weight:180.15142Cefepime Related Compound D ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C6H7N3O3SColor and Shape:Off-White Light Brown PowderMolecular weight:201.02081Atenolol Related Compound F (2,2'-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl)]bis(oxy)}bis(4,1-phenylene)]diacetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C25H35N3O6Color and Shape:White PowderMolecular weight:473.25259

